C3.
| Revenue (TTM) | $232.38M |
| Gross Profit (TTM) | $67.61M |
| EBITDA | $-447.08M |
| Operating Margin | -186.30% |
| Return on Equity | -59.80% |
| Return on Assets | -31.20% |
| Revenue/Share (TTM) | $1.60 |
| Book Value | $4.35 |
| Price-to-Book | 2.51 |
| Price-to-Sales (TTM) | 7.83 |
| EV/Revenue | 4.737 |
| EV/EBITDA | -2.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -25.50% |
| Shares Outstanding | $157.28M |
| Float | $144.21M |
| % Insiders | 8.10% |
| % Institutions | 62.87% |
Volatility is currently expanding
U.S. companies and the Trump administration both "need to be wary" of AI-related foreign espionage attempts, Director of National Intelligence Jay Clayton told CNBC. Clayton was asked how concerned Americans should be in light of the recently revealed case charging Saudi national Abdulrahman Alfozan with installing a recording device in an OpenAI conference room.
C3.ai (AI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Rising fiscal deficits could make it harder for governments to meet their financial obligations and handle risks of the future.
C3.ai is transitioning its business model toward consumption-based pricing to expand its reach among mid-sized enterprise customers. UiPath achieved positive net income in fiscal 2026 while continuing to scale its AI-driven automation platform for global organizations.
C3.ai Inc (AI) stock is pushing higher on Monday morning after Northland Capital issued a bullish note in favour of the enterprise artificial intelligence software company. In his research note, analyst Mike Latimore upgraded AI to Outperform, and raised his price target to $16, indicating potential upside of more than 40% from its previous close.
Agentic software names are splitting apart, and the gap says a lot about how the market grades this group. SoundHound AI (NASDAQ:SOUN) stock is at $5.14, down 5% early in the session and sitting at fresh lows.
Zacks.com users have recently been watching C3.ai (AI) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Basecamp Research said on Wednesday it has raised $140 million in a Series C funding round that valued the AI-based drug developer at $800 million.
Recently, Zacks.com users have been paying close attention to C3.ai (AI). This makes it worthwhile to examine what the stock has in store.
Speculative software names are absorbing most of the day's selling on Wednesday midday, even as the broader U.S. market drifts higher. The iShares Expanded Tech-Software Sector ETF (CBOE:IGV) sits at $105.36, down 0.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AI and any ticker you trade — then tracks every position and per-strategy win rate.
